Founders Financial Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Founders Financial Securities's VRTX Position: Q3 2026 in Review
Founders Financial Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 28% in Q3 2026, selling an estimated $456K and leaving 2,294 shares worth $1.2M. The position accounts for 0.06% of the portfolio, ranked #286.
Founders Financial Securities first reported a position in VRTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.66M in Q4 2025. 1,748 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Founders Financial Securities held 2,294 shares of Vertex Pharmaceuticals worth $1.2M as of Q3 2026.
- Founders Financial Securities sold 891 Vertex Pharmaceuticals shares in Q3 2026, an estimated $456K.
- Vertex Pharmaceuticals made up 0.06% of Founders Financial Securities's portfolio in Q3 2026, its #286 holding.
- Founders Financial Securities first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
- Founders Financial Securities's Vertex Pharmaceuticals position peaked at $1.66M in Q4 2025.
- 1,748 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Founders Financial Securities's 13F filing for Q3 2026, filed 28 Oct 2026.